Zota Health Care Ltd: AGM Voting Results Show Strong Shareholder Approval
Zota Health Care Limited's 26th AGM on September 28, 2026, saw all resolutions approved. Key approvals include FY26 financial statements, a 10% dividend for FY25-26, director re-appointments, and related party transactions. The company appointed Mr. Mahaveer Dhariwal as Independent Director.
The approval of financial statements, dividend declaration, and key director appointments are significant corporate actions that can influence investor perception and company strategy.
The announcement details the approval of all resolutions at the AGM, including financial statements, dividend, and director appointments, indicating positive corporate governance and shareholder confidence.
Zota Health Care Limited has announced the voting results from its 26th Annual General Meeting (AGM), which was held on Monday, September 28, 2026, at 11:00 AM through Video Conferencing via the NSDL virtual platform.
All resolutions presented at the AGM were duly approved by the shareholders with the requisite majority, according to the Scrutinizer's Report. The company had appointed Mr. Ranjit Binod Kejriwal, Practicing Company Secretaries, as the Scrutinizer to ensure a fair and transparent voting process for both remote e-voting and e-voting during the AGM.
The approved resolutions included the adoption of audited standalone and consolidated financial statements for the financial year ended March 31, 2026, the declaration of a final dividend of 10% (₹1 per equity share) for FY 2025-26, the re-appointment of Mr. Kamlesh Rajanikant Zota as a Whole-Time Director, the appointment of Mr. Mahaveer Dhariwal as an Independent Director, and the re-appointment of Mr. Moxesh Ketanbhai Zota as the Managing Director.
Additionally, shareholders approved the remuneration for Mr. Ketankumar Chandulal Zota, Non-Executive Chairman, and related party transactions, including remuneration to directors and senior marketing managers, and material related party transactions with its subsidiary, M/s Everyday Herbal Beauty Care Limited. The voting results and the Scrutinizer's Report have been published on the company's website (www.zotahealthcare.com) and are available at the registered office.
What to do with a filing like this
Zota Health Care LImited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Zota Health Care LImited. Read the original for the full detail.